Schonfeld Strategic Advisors’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,195
| Closed | -$532K | – | 2967 |
|
|
2022
Q1 | $532K | Buy |
2,195
+1,076
| +96% | +$261K | ﹤0.01% | 1260 |
|
|
2021
Q4 | $338K | Buy |
+1,119
| New | +$338K | ﹤0.01% | 1396 |
|
|
2021
Q3 | – | Sell |
-137
| Closed | -$42K | – | 2369 |
|
|
2021
Q2 | $42K | Buy |
+137
| New | +$42K | ﹤0.01% | 1834 |
|
|
2020
Q3 | – | Sell |
-669
| Closed | -$166K | – | 1662 |
|
|
2020
Q2 | $166K | Buy |
+669
| New | +$166K | ﹤0.01% | 1091 |
|
|
2020
Q1 | – | Sell |
-318
| Closed | -$92K | – | 1574 |
|
|
2019
Q4 | $92K | Sell |
318
-3,887
| -92% | -$1.12M | ﹤0.01% | 1212 |
|
|
2019
Q3 | $1.15M | Buy |
+4,205
| New | +$1.15M | 0.03% | 437 |
|
|
2019
Q2 | – | Sell |
-1,875
| Closed | -$503K | – | 1283 |
|
|
2019
Q1 | $503K | Hold |
1,875
| – | – | 0.02% | 688 |
|
|
2018
Q4 | $399K | Sell |
1,875
-3,125
| -63% | -$665K | 0.02% | 730 |
|
|
2018
Q3 | $2.24M | Sell |
5,000
-5,358
| -52% | -$2.4M | 0.1% | 260 |
|
|
2018
Q2 | $4.2M | Sell |
10,358
-25
| -0.2% | -$10.1K | 0.23% | 152 |
|
|
2018
Q1 | $5.67M | Buy |
10,383
+1,945
| +23% | +$1.06M | 0.43% | 54 |
|
|
2017
Q4 | $5.1M | Sell |
8,438
-625
| -7% | -$377K | 0.42% | 68 |
|
|
2017
Q3 | $4.18M | Sell |
9,063
-1,062
| -10% | -$489K | 0.38% | 80 |
|
|
2017
Q2 | $4.1M | Buy |
+10,125
| New | +$4.1M | 0.42% | 51 |
|